Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/28/23 17:30 | 9/26/23 | SGMO | Health | BioPrd | Biological Products, (No Diag | Biogen Inc. | MA | T | S | -3,000 | 0.5000 | 0 | -6,000 | -25 | 17,652 | I | |||||||||||||||
8/31/22 19:03 | 8/29/22 | SGMO | Health | BioPrd | Biological Products, (No Diag | Biogen Inc. | MA | T | S.m | -2,657 | 5.31 | 0 | -500 | -2 | 23,652 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |